Acusphere, Inc. (ACUS)

Market Cap	5.00 -100.0%
Revenue (ttm)	2.68M +0.6%
Net Income	-69.42M
EPS	-14.64
Shares Out	4.95M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3,713
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0000 - 0.0001
Beta	-0.52
RSI	43.22
Earnings Date	n/a

About Acusphere

Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 118
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACUS

Financial Performance

In 2008, Acusphere's revenue was $2.68 million, an increase of 0.64% compared to the previous year's $2.67 million. Losses were -$69.42 million, 24.0% more than in 2007.